← All trials
NCT06485245
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 14, 2024
- Primary completion
- Apr 29, 2025
- Completion date
- Sep 30, 2025
- First posted
- Jul 3, 2024
- Last posted
- Jul 30, 2024
- Enrollment
- 80
- Arms / groups
- 10 / —
- Source
- AACT · ctgov ingestion
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.